
BPC/TB-500
Ships fully reconstituted · no mixing, no powder, no bacteriostatic waterThe Ultimate Recovery Combo
Dual-action recovery blend combining targeted repair with systemic anti-inflammation.
Choose your supply
Frequently paired with
What it supports
- Targeted + systemic tissue repair
- Accelerated injury recovery
- Reduced inflammation body-wide
- Enhanced tendon, ligament, and muscle healing
- Improved joint mobility
- Gut healing support
- Faster post-surgical recovery
The details
- Administration
- Subcutaneous injection
- Format
- 3mg/mL (BPC-157) + 5mg/mL (TB-500), 5mL vial
- Typical dosing
- Per provider guidance, subcutaneous injection daily
- Best for
- Injury recovery, post-surgery healing, tissue repair
- Pairs well with
- CJC-1295/Ipamorelin, GHK-Cu
How it works
Signal
BPC/TB-500 is given as a single daily subcutaneous injection on a provider-determined schedule.
Cellular response
BPC-157 promotes angiogenesis and growth-factor recruitment at the injury site, while TB-500 upregulates actin for cell migration and reduces systemic inflammation. Together they cover both local and whole-body repair pathways.
Outcome
Over the following weeks most people notice pain, stiffness, and swelling drop first — gut symptoms easing too if relevant (weeks 1–2), then real mobility and faster workout recovery (weeks 2–4), then the injured area feeling stable and strong, not just less painful (weeks 4–8), with full return to activity from week 8 onward.
Research highlights
Both peptides well-documented for tissue healing
Complementary mechanisms of action
Most commonly paired peptides in regenerative protocols
Research supports synergistic healing effects
Research summaries are provided for educational context and are not a promise of results. Talk with your provider about what to expect.
Sources & references
BPC-157 accelerates tendon healing
Chang CH et al. J Appl Physiol. 2011;110(3):774–780.
View sourceTB-500 promotes tissue repair (review)
Goldstein AL et al. Ann N Y Acad Sci. 2012;1270:1–8.
View sourceComplementary mechanisms support combination use
Sikiric P et al. Curr Pharm Des. 2019;25(12):1362–1367.
View source
Common questions
Important safety information
BPC/TB-500 is available by prescription only and is dispensed after a licensed provider reviews your medical screening and determines it is appropriate for you. Compounded medications are prepared by a licensed U.S. pharmacy and are not FDA-approved products. Tell your provider about your full medical history and any medications you take.
- • Generally well tolerated
- • Possible injection site reactions
- • Not for use with active cancer
- • Requires licensed provider supervision


